EDGAR Filing Documents for 0001193125-15-089238

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-15-089238

Filing Date

2015-03-12

Accepted

2015-03-12 16:12:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d889911ds3.htm	S-3	376400
2	EXHIBIT 1.2	d889911dex12.htm	EX-1.2	158444
3	EXHIBIT 4.1	d889911dex41.htm	EX-4.1	333806
4	EXHIBIT 4.3	d889911dex43.htm	EX-4.3	3173
5	EX-4.8	d889911dex48.htm	EX-4.8	113582
6	EXHIBIT 5.1	d889911dex51.htm	EX-5.1	39776
7	EXHIBIT 23.3	d889911dex233.htm	EX-23.3	1440
8	GRAPHIC	g889911g50u83.jpg	GRAPHIC	3346
9	GRAPHIC	g889911g55i91.jpg	GRAPHIC	23929
10	GRAPHIC	g889911image00.jpg	GRAPHIC	315940
11	GRAPHIC	g889911image001.jpg	GRAPHIC	80033
	Complete submission text file	0001193125-15-089238.txt		1611348

Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472

Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097

Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)